FindTrial
Sign In

Evaluation of efficacy and safety of modified ethanol sclerotherapy for simple renal cyst

Clinical application of minimally invasive sclerotherapy for renal cyst guided by MSCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026082
Enrollment
Unknown
Registered
2019-09-20
Start date
2021-01-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple Renal Cysts

Interventions

Experimental group:Preinjection of low-dose intracystic lidocaine
Increase the volume of injected ethanol
Control group:Conventional treatment

Sponsors

Dianjiang County People's Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: All patients enrolled in the study were diagnosed with SRCs using ultrasound or CT examination prior to the procedure and met the following inclusion criteria: cyst diameter between 5–8 cm with symptoms, such as flank pain or discomfort, mass, or hypertension.

Exclusion criteria

Exclusion criteria: Patients with peripelvic cysts, previously treated cysts, or procedural contraindications were excluded.

Design outcomes

Primary

MeasureTime frame
Visual analog pain score;Cyst size;—

Secondary

MeasureTime frame
Renal morphologic volume;—

Countries

China

Contacts

Public ContactHao Zhang

Dianjiang County People's Hospital of Chongqing

6472988@qq.com+86 13896573520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026